| angioimmunoblastic lymphadenopathy with dysproteinemia | ||||
| Disease ID | 1056 |
|---|---|
| Disease | angioimmunoblastic lymphadenopathy with dysproteinemia |
| Definition | A disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly. |
| Synonym | [m] angioimmunoblastic lymphadenopathy [m]angioimmunoblastic lymphadenopathy aild ailt angioblastic lymphadenopathy angioimmunoblastic lymphadenopathies angioimmunoblastic lymphadenopathy angioimmunoblastic lymphadenopathy (morphologic abnormality) angioimmunoblastic lymphadenopathy type t-cell lymphoma angioimmunoblastic lymphadenopathy with dysproteinaemia angioimmunoblastic lymphadenopathy with dysproteinemia (aild) angioimmunoblastic lymphadenopathy with dysproteinemia (disorder) angioimmunoblastic lymphoma angioimmunoblastic t-cell lymphoma angioimmunoblastic t-cell lymphoma (disorder) angioimmunoblastic t-cell lymphoma (morphologic abnormality) immunoblastic lymphadenopathies immunoblastic lymphadenopathy immunoblastic lymphadenopathy [disease/finding] lymphadenopathies, angioimmunoblastic lymphadenopathies, immunoblastic lymphadenopathy, angioimmunoblastic lymphadenopathy, angioimmunoblastic, with dysproteinemia lymphadenopathy, immunoblastic peripheral t-cell lymphoma, aild (angioimmunoblastic lymphadenopathy with dysproteinaemia) peripheral t-cell lymphoma, aild (angioimmunoblastic lymphadenopathy with dysproteinemia) |
| Orphanet | |
| ICD10 | |
| UMLS | C0020981 |
| MeSH | |
| SNOMED-CT | |
| Comorbidity | UMLS | Disease | Sentences' Count(Total Sentences:26) C0024299 | lymphoma | 4 C0079731 | b-cell lymphoma | 3 C0079744 | diffuse large b-cell lymphoma | 2 C0079731 | b-cell lymphomas | 2 C0024299 | lymphomas | 2 C0019829 | hodgkin's lymphoma | 1 C0035078 | renal failure | 1 C0079731 | b cell lymphoma | 1 C0242584 | autoimmune thrombocytopenia | 1 C0272286 | immune thrombocytopenia | 1 C0023418 | leukemia | 1 C0031036 | polyarteritis nodosa | 1 C0024291 | hemophagocytic lymphohistiocytosis | 1 C0002878 | hemolytic anemia | 1 C0272126 | evans syndrome | 1 C0002871 | anemia | 1 C0032285 | pneumonia | 1 C0034902 | pure red cell aplasia | 1 C0030807 | pemphigus | 1 C1522378 | large granular lymphocytosis | 1 C0151436 | leukocytoclastic vasculitis | 1 C0023484 | plasma cell leukemia | 1 C0281963 | red cell aplasia | 1 C0026764 | plasma cell myeloma | 1 C0085278 | antiphospholipid syndrome | 1 C0002880 | autoimmune hemolytic anemia | 1 |
| Curated Gene | Entrez_id | Symbol | Resource(Total Genes:4) |
| Inferring Gene | (Waiting for update.) |
| Text Mined Gene | (Waiting for update.) |
| Locus | (Waiting for update.) |
| Disease ID | 1056 |
|---|---|
| Disease | angioimmunoblastic lymphadenopathy with dysproteinemia |
| Integrated Phenotype | (Waiting for update.) |
| Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:16) HP:0012191 | B-cell lymphoma | 4 HP:0002665 | Lymphoma | 4 HP:0002716 | Lymph node hyperplasia | 3 HP:0002664 | Neoplasia | 2 HP:0002958 | Immune dysregulation | 1 HP:0001880 | Eosinophilia | 1 HP:0002090 | Pneumonia | 1 HP:0001878 | Haemolytic anaemia | 1 HP:0001909 | Leukemia | 1 HP:0001903 | Anemia | 1 HP:0000083 | Renal insufficiency | 1 HP:0012189 | Hodgkin disease | 1 HP:0001890 | Autoimmune hemolytic anemia | 1 HP:0012410 | Pure red cell aplasia | 1 HP:0001973 | Autoimmune thrombocytopenia | 1 HP:0030150 | Plasmacytosis | 1 |
| Disease ID | 1056 |
|---|---|
| Disease | angioimmunoblastic lymphadenopathy with dysproteinemia |
| Manually Symptom | (Waiting for update.) |
| Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:2) |
Manually Genotype(Total Text Mining Genotypes:0) |
|---|
| (Waiting for update.) |
All Snps(Total Genotypes:3) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
| rs113488022 | 24689848 | 387 | RHOA | umls:C0020981 | BeFree | They include the V600E BRAF mutation in hairy cell leukemia, the L265P MYD88 mutation in Waldenström macroglobulinemia, the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified, and the Y640F//D661Y/V/H/I//N647I STAT3 mutations in T-cell large granular lymphocytic leukemia. | 0.121357209 | 2014 | BRAF | 7 | 140753336 | A | T,G,C |
| rs371896760 | 24689848 | 387 | RHOA | umls:C0020981 | BeFree | They include the V600E BRAF mutation in hairy cell leukemia, the L265P MYD88 mutation in Waldenström macroglobulinemia, the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified, and the Y640F//D661Y/V/H/I//N647I STAT3 mutations in T-cell large granular lymphocytic leukemia. | 0.121357209 | 2014 | ACAA1;MYD88 | 3 | 38138714 | G | T |
| rs387907272 | 24689848 | 387 | RHOA | umls:C0020981 | BeFree | They include the V600E BRAF mutation in hairy cell leukemia, the L265P MYD88 mutation in Waldenström macroglobulinemia, the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified, and the Y640F//D661Y/V/H/I//N647I STAT3 mutations in T-cell large granular lymphocytic leukemia. | 0.121357209 | 2014 | MYD88 | 3 | 38141150 | T | C |
GWASdb Annotation(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
GWASdb Snp Trait(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
Mapped by lexical matching(Total Items:0) |
|---|
| (Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
|---|
| (Waiting for update.) |
Chemical(Total Drugs:1) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
| C0020981 | phenytoin | D010672 | 57-41-0 | immunoblastic lymphadenopathy | MESH:D007119 | marker/mechanism | 7336147 | ||
FDA approved drug and dosage information(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |
FDA labeling changes(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |